コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 CaMK and Pyk2 relayed signals from integrins and the ITA
2 CaMK induced expression of peroxisome proliferator-activ
3 CaMK inhibition suppressed STAT1-mediated interferon-alp
4 CaMK phosphorylates serines -259 and -498 in HDAC5, whic
5 CaMK reciprocally enhanced L-type Ca(2+) current and red
6 CaMK regulation of CP-AMPARs was also confirmed in hippo
7 CaMK stimulates MEF2 activity by dissociating class II h
8 CaMK was contained only in pyramidal neurons; GABA was c
9 CaMK-II is transiently activated in approximately four i
10 Ca2+/calmodulin-dependent protein kinase-2 [CaMK-2] [Kd = 300-400 nmol/l at 10(-5) mol/l [Ca2+]]).
12 inction recruited calcium/calmodulin (Ca(2+)/CaMK)-dependent protein kinase II (CaMKII) to the hippoc
13 lar concentration of factors such as 14-3-3, CaMK I, and other yet unknown molecules may determine th
15 expression in CA1 pyramidal neurons causes a CaMK- and PKC-dependent potentiation of AMPAR-mediated t
20 emonstrate that intra-amygdala infusion of a CaMK inhibitor, 1-[NO-bis-1,5-isoquinolinesulfonyl]-N-me
23 lized to the cell nucleus, and the activated CaMK-IV disrupted HDAC4/SRF association, leading to expo
25 ough seven genes encode catalytically active CaMK-II in early zebrafish embryos, one of these genes a
28 lls and cilia, whereas constitutively active CaMK-II restores pronephric duct formation in pkd2 morph
31 +) axon terminals were seen to innervate all CaMK(+) postsynaptic domains, including cell bodies (22%
33 ral level of glutamate receptor activity and CaMK-dependent signaling are critical for development of
34 + release was required for both Ca2+-CaM and CaMK ICa-L responses after strongly positive conditionin
36 rately test the relationship of Ca2+-CaM and CaMK to ICa-L and SR Ca2+i release during voltage clamp
37 element for ICa-L responses to Ca2+-CaM and CaMK, and the C terminus undergoes voltage-dependent ste
39 indicating that SKF83959 stimulates cdk5 and CaMK II activities via a PI-linked D1-like dopamine rece
43 ifferentially impact DRD-2, DAT, CaMK II and CaMK IV mRNA, protein and intracellular expression compa
45 osphorylation of Galpha11 protein by PKC and CaMK contributes to agonist-induced homologous desensiti
46 ctivated by NGF involves PI3K, while PKC and CaMK II are also involved, probably at subsequent stages
50 e of PKC translocation was apparent, PKC and CaMKs were required for activation and nuclear transloca
52 Jun NH(2)-terminal kinase, protein kinase B, CaMK II, protein kinase Calpha, and protein kinase Cdelt
53 irtually every pyramidal cell appeared to be CaMK(+), the cell bodies of small nonpyramidal neurons w
55 f beta2 CaMK-II (camk2b2), but not the beta1 CaMK-II (camk2b1) paralog, exhibit bradycardia, elongate
57 and gamma1 CaMK-II; however, alphaKAP, beta2 CaMK-II and the RyR3 ryanodine receptor were also necess
59 oneal M that was attenuated with biochemical CaMK inhibition or CaMKIalpha small interfering RNA (siR
63 ylation of the APC/C inhibitor XErp1/Emi2 by CaMK II renders it a good substrate for Plx1, and phosph
67 ked activation of the c-fos gene promoter by CaMK II 290, a constitutively active form of CaMK IIalph
73 targets of SOM+ terminals were small-caliber CaMK+ dendrites and dendritic spines, some of which were
74 y lower compared with that of the calmodulin-CaMK-2 association (K0.5 = 40 micromol/l [Ca2+], maximal
76 To further define the mechanisms that confer CaMK responsiveness to HDAC4 and -5, we performed yeast
77 a heterologous gene is sufficient to confer CaMK IV repression on an otherwise constitutive exon.
80 de B gp120 differentially impact DRD-2, DAT, CaMK II and CaMK IV mRNA, protein and intracellular expr
85 efine a targeting domain for gamma and delta CaMK-IIs that is in between the central variable and ass
88 indicate that persistent activation of delta CaMK-II by laminin stabilizes nascent embryonic axons th
95 the subcellular targeting domain of delta(E) CaMK-II, an isozyme that induces neurite outgrowth, and
100 e show in hippocampal neurons that the fast, CaMK-dependent pathway can be followed by a slower pathw
102 hes, the present findings support a role for CaMK kinase in mediating mGluR5-dependent cyclic adenosi
104 idea that S18 could be a novel substrate for CaMK II, thus providing a potential link between Ca(2+)-
105 ngs identify MEF2 as a downstream target for CaMK signaling in the hypertrophic heart and suggest tha
111 ntact KV, the PKD2 Ca(2+) channel and gamma1 CaMK-II; however, alphaKAP, beta2 CaMK-II and the RyR3 r
113 cium-calmodulin-dependent protein kinase II (CaMK II) activation also prevented NGF-induced sensitisa
115 (2+)/calmodulin-activated protein kinase II (CaMK II) is abundantly expressed in vascular smooth musc
117 Ca2+/calmodulin-dependent protein kinase II (CaMK II), which is activated by elevated [Ca2+]i, increa
118 Ca2+-calmodulin-dependent protein kinase II (CaMK) and a calmodulin (CaM)-binding 'IQ' domain (IQ) ar
119 (LTCC) C terminus and calmodulin kinase II (CaMK) both signal increases in LTCC opening probability
120 cium/calmodulin-dependent protein kinase II (CaMK) has been shown to play a critical role in long-ter
123 cium/calmodulin-dependent protein kinase II (CaMK) was used as a marker for pyramidal cells, the prin
125 cium/calmodulin-dependent protein kinase II (CaMK); previous studies have shown that the vast majorit
126 (2+)/calmodulin-dependent protein kinase II (CaMK-II) isozyme variability is the result of alternativ
129 molecules and signaling pathways, including CaMK, PKA, Casein kinase-II, and the Raf-MEK-ERK and PI-
132 or of many of these morphogenic processes is CaMK-II, a conserved calmodulin-dependent protein kinase
134 Signaling by the Ca(2+)/calmodulin kinase (CaMK) cascade has been implicated in neuronal gene trans
137 r effector of the Ca(2+) /calmodulin kinase (CaMK) pathway where it coordinates transcriptional respo
138 neurons, serotonin uses a calmodulin kinase (CaMK)-dependent signaling cascade involving CaMKKbeta an
139 H(2)O(2) activates Ca(2+)/calmodulin kinase (CaMK)II, which also impairs I(Na) inactivation and promo
141 KC) and calcium/calmodulin dependent kinase (CaMK) consensus site in Galpha11 significantly reduced D
142 ided by calcium/calmodulin-dependent kinase (CaMK) disrupt the interaction of MITR and HDACs with HP1
143 tion of calcium calmodulin-dependent kinase (CaMK) has no effect, but pERK is reduced by inhibition o
150 Calcium/calmodulin-dependent protein kinase (CaMK) activation induces mitochondrial biogenesis in res
151 calcium/calmodulin-dependent protein kinase (CaMK) and extracellular signal-regulated kinase 1/2 (ERK
152 calcium/calmodulin-dependent protein kinase (CaMK) cascade that is comprised of CaMK kinase (CaMKK) a
154 m/calmodulin (CaM)-dependent protein kinase (CaMK) I and insulin-like growth factor (IGF) II (Igf2) i
156 Ca(2+) /calmodulin-dependent protein kinase (CaMK) I. gamma-Aminobutyric acid (GABA) affects cell fun
157 tion of calmodulin-dependent protein kinase (CaMK) II and cAMP response element-binding protein (CREB
158 calcium/calmodulin-dependent protein kinase (CaMK) II in dorsal CA1 does not affect retention of this
160 calcium/calmodulin-dependent protein kinase (CaMK) IV serine phosphorylates and mediates the release
161 calcium calmodulin-dependent protein kinase (CaMK) pathway, a major pathway of CREB activation--fear
162 Calcium/calmodulin-dependent protein kinase (CaMK) signaling promotes myogenesis by disrupting MEF2-H
163 Ca(2+)/calmodulin-dependent protein kinase (CaMK) type IV, which was attenuated by calpain inhibitor
164 Ca(2+)/calmodulin-dependent protein kinase (CaMK), and cyclic adenosine 3',5'-monophosphate-responsi
165 calcium-calmodulin-dependent protein kinase (CaMK)-dependent binding of 14-3-3 to phosphoserines 259
166 of Ca2+/calmodulin-dependent protein kinase (CaMK)-IV prevented SRF/HDAC4 interaction and derepressed
167 calcium/calmodulin-dependent protein kinase (CaMK)-type domain of RSK1 is reminiscent of the better k
168 Ca(2+)/calmodulin-dependent protein kinase (CaMK)/p25 double-transgenic model of tauopathic degenera
169 calcium/calmodulin-dependent protein kinase (CaMK)Ialpha regulates the inflammatory phenotype of the
170 calcium/calmodulin-dependent protein kinase (CaMK)II and downstream MEK and ERK MAPKs that are import
171 study, Ca(2+)/CaM-dependent protein kinase (CaMK-II) is identified as a necessary target of this Ca(
172 II Ca2+/calmodulin-dependent protein kinase (CaMK-II), which is preferentially activated in hair cell
173 he function of the calcium-dependent kinases CaMK and Pyk2 'downstream' of ITAM-associated receptors
174 tional calcium/calmodulin-dependent kinases (CaMK), KN-93, arrests a variety of cell types in G(1).
175 cantly similar to those of both CaM kinases (CaMKs) and doublecortin, the product of the gene mutated
176 levated calcium are mediated by CaM kinases (CaMKs), a family of protein kinases whose activities are
178 including the calmodulin-dependent kinases (CaMKs) and the ERKs (extracellular signal-regulated kina
179 es such as the calmodulin-dependent kinases (CaMKs) and the extracellular signal-regulated kinases (E
181 ibited several calmodulin-dependent kinases (CaMKs) competitively with Ca(2+)/calmodulin (Ca(2+)/CaM)
183 ion of calcium/calmodulin-dependent kinases (CaMKs), a family of proteins involved in a wide range of
184 Ca(2+)/calmodulin-dependent protein kinases (CaMKs) and RARs that modulates the differentiation of my
185 Ca(2+)/calmodulin-dependent protein kinases (CaMKs) are major downstream mediators of neuronal calciu
186 Ca(2+)/calmodulin-dependent protein kinases (CaMKs) with KN-62 reduces SGN survival independently of
187 PRKs), calmodulin-dependent protein kinases (CaMKs), calcium and calmodulin-dependent protein kinases
194 related behavior, cortical activity and mPFC CaMK components, implicating cellular and molecular mech
196 es, as well as KV-targeted dominant negative CaMK-II, randomize organ laterality and southpaw (spaw)
197 ion using a combination of dominant-negative CaMKs (dnCaMKs) and other specific CaMK inhibitors.
198 ssing constitutively active CaMK IV, but not CaMK I or II, specifically decreases STREX inclusion in
199 report that PV+ interneurons employ a novel CaMK-dependent pathway to trigger CREB phosphorylation a
200 generality of CaM shuttling to drive nuclear CaMK activity, and they are relevant to disease pathophy
203 by approximately 10-fold, and the amount of CaMK kinase (an upstream activator of CaMKIV) protein an
204 ia HP1-MITR and HP1-HDAC interactions and of CaMK signaling to disrupt these interactions provides an
205 DeltaD protein accumulates in hair cells of CaMK-II morphants, indicative of defective recycling and
206 n kinase (CaMK) cascade that is comprised of CaMK kinase (CaMKK) and its primary downstream substrate
208 ing an engineered Ca(2+)-independent form of CaMK and a highly specific CaMK inhibitory peptide.
210 morpholino oligonucleotides or inhibition of CaMK-II activation by the pharmacological antagonist, KN
214 ethods to study the neuronal localization of CaMK, and its relationship to gamma-aminobutyric acid (G
215 hibition of either cdk5 by roscovitine or of CaMK by 2-[N-(2-hydroxyethyl)]-N-(4-methoxybenzenesulfon
216 increased expression and phosphorylation of CaMK II in rat spinal dorsal horn neurons after noxious
218 There are few, if any, known substrates of CaMK II that are physiologically relevant in vascular sm
222 hat SKF83959-mediated stimulation of cdk5 or CaMK II is independent of the other kinase and that the
224 IV levels, suggesting the involvement of PFC CaMK pathways in COMT-regulated cognitive function and a
226 (CD29) also reduced axon length and phospho-CaMK-II levels and, like CaMK-II inhibitors, decreased C
229 uclear translocation, whereas a proapoptotic CaMK inhibitor stimulates HDAC4 nuclear accumulation.
230 rapid CaMK signaling to pCREB or both rapid CaMK and slow MAPK signaling deviated significantly for
231 The Ca(2+) signals that produced only rapid CaMK signaling to pCREB or both rapid CaMK and slow MAPK
232 timulation of c-Src by endothelin-1 required CaMK II activity, further supporting the notion that CaM
238 and this effect was prevented by a specific CaMK inhibitory peptide, but not by an inactive control
242 a suggest that drugs that selectively target CaMKs and regulate protein synthesis offer novel strateg
243 supports a model in which membrane targeted CaMK-II hetero-oligomers in nodal cells transduce the le
245 the ultrastructural level, it was found that CaMK was localized to pyramidal cell bodies, thick proxi
246 These findings support the hypothesis that CaMK is required for physiological I(Ca) facilitation in
247 These findings support the hypothesis that CaMK is required to functionally couple LTCC and RyR dur
250 favoured prolonged openings, indicating that CaMK and IQmp affect LTCCs through a common biophysical
251 activity, further supporting the notion that CaMK II acts upstream of Src in a signaling cassette.
252 immunofluorescence microscopy revealed that CaMK and GABA were found in different neuronal populatio
255 and IQmp were non-additive, suggesting that CaMK and IQmp are components of a shared signalling path
261 ormation was overwhelmingly dominated by the CaMK pathway between 0 and 10 min, and by the MAPK pathw
262 that eliminate gene products containing the CaMK-like and L27 domains (CASK-beta), but do not affect
263 Here, we describe a requirement for the CaMK-kinase (CaMKK) pathway upstream of ERK in LTP induc
265 iew summarizes key neuronal functions of the CaMK cascade in signal transduction, gene transcription,
266 of upstream and downstream components of the CaMK cascade may serve distinct physiological functions.
267 pha) isoform is an upstream component of the CaMK cascade whose function in different behavioral and
270 e II (CaMKII), although other members of the CaMK family are highly expressed in developing neurons.
271 e-associated' (CaMKv), a pseudokinase of the CaMK family with unknown function, as a synaptic protein
273 s the expression of a specific member of the CaMK-II (the type II multifunctional Ca(2+)/calmodulin-d
274 n diminished RANKL-induced activation of the CaMK-MEK-ERK pathway and decreased expression of the mas
275 the hypertrophic heart and suggest that the CaMK and calcineurin pathways preferentially target diff
276 n together, this study demonstrates that the CaMK II/CREB/Wnt/beta-catenin signaling cascade plays an
277 CaMKK2 is one of the most versatile of the CaMKs and will phosphorylate and activate CaMKI, CaMKIV,
278 KN62, a pharmacological inhibitor of the CaMKs, enhances the terminal differentiation of myeloid
281 dulin-dependent protein kinase) family; this CaMK-II is necessary for proper heart and fin developmen
283 o CaMK phosphorylation sites is resistant to CaMK-mediated nuclear export and acts as a dominant inhi
284 These findings show that ICa-L responses to CaMK are voltage dependent and suggest a new model of L-
292 myocytes were studied under conditions where CaMK activity could be controlled independently of intra
293 P-regulated phosphoprotein at Thr75, whereas CaMK II is responsible for the activation of cAMP respon
295 n this study, we sought to determine whether CaMK-II is activated by laminin, and if so, how CaMK-II
296 ic peptide (IQmp), under conditions in which CaMK activity was controlled, to test the relationship b